Tracks recovery after sarcoma surgery using a smartphone app
Follows adults with sarcoma after surgery using a phone app.
Plain-language title generated from the registry record
Registry title: Activation Sarcoma: PROMIS and Mobility Evaluation in Sarcoma Patients
Key facts
- Where
- Calgary and Toronto, CanadaSee the 2 sites
Where in Canada
- Foothills Medical Centre, Arthur J Child Comprehensive Cancer Centre, University of CalgaryCalgary, CanadaTaking people
- Mount Sinai Hospital, University of TorontoToronto, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Calgary
- Trial code
- NCT07227961
- Record updated
- 2 November 2026
- Original description
Sarcoma is a rare form of bone and soft tissue cancer, making up about 1% of all adult cancers. Management typically involves radiation therapy, chemotherapy, and surgical resection. Surgery is central to the treatment of bone and soft tissue sarcoma, yet post-surgical recovery is difficult to measure because of disease rarity, multiple different tumor types, and treatment variation. Therefore, the overall goal of the study is to use patient reported outcome measures and mobility data to define recovery trajectories in sarcoma patients undergoing surgery, and to evaluate a novel smartphone application (app) entailed Activation Health for collecting these data.Read full original descriptionShow less
Patient-Reported Outcomes and Smartphone-Derived Mobility After Bone and Soft Tissue Sarcoma Surgery: A Multicentre Prospective Cohort Study
Sarcoma is a rare form of bone and soft tissue cancer, making up about 1% of all adult cancers. Management typically involves radiation therapy, chemotherapy, and surgical resection. Surgery is central to the treatment of bone and soft tissue sarcoma, yet post-surgical recovery is difficult to measure because of disease rarity, multiple different tumor types, and treatment variation. Therefore, the overall goal of the study is to use patient reported outcome measures and mobility data to define recovery trajectories in sarcoma patients undergoing surgery, and to evaluate a novel smartphone application (app) entailed Activation Health for collecting these data.
Participants will download the Activation Health app on their smartphone. A demographics survey and multiple patient reported outcome measures will be administered remotely through the Activation Health app. Surveys will be completed preoperatively and at 6 weeks, 12 weeks, 6 months 12 months, 16 months, 20 months, and 24 months postoperatively. Additionally, the app will passively track mobility metrics such as daily step count, stairs climbed, and gait parameters throughout the study period. At the end of study participation, an additional surveys will be administered assess participant phone use habits and app function.
Inclusion: Age ≥ 18 years; Diagnosis of bone sarcoma, soft tissue sarcoma, or giant cell tumor of bone; Tumors located in the pelvis, lower extremities, or upper extremities; Primary or recurrent disease; Undergoing operative tumor resection, including limb salvage surgery and amputation; Has an iPhone or Android smartphone; Speaks English.
Exclusion: Metastatic bone tumor; Diagnosis of atypical lipomatous tumor; Diagnosis of dermatofibrosarcoma protuberans; Currently pregnant or planning pregnancy within 6 months; Unwilling or unable to attend follow-up evaluations; Cognitive or communication barriers that impede completion of questionnaires.